Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2016.11.19
关于增添2016年一样平常谋划性关联生意预计金额的通告
2016.11.19
第三届董事会第二十八次聚会决议通告
2016.11.19
关于开展交织钱币掉期营业的可行性剖析报告
2016.11.19
关于对全资子公司Hepalink USA Inc.增资的通告
2016.11.19
关于新增召募资金专项存储账户的通告
2016.11.19
关于公司与汇丰银行举行交织钱币掉期生意的通告
2016.11.19
第三届监事会第二十次聚会决议通告
2016.11.19
关于全资子公司对外投资的通告
2016.11.10
2016年面向及格投资者果真刊行公司债券刊行效果通告
2016.11.08
2016年面向及格投资者果真刊行公司债券票面利率通告
第一页
上一页
80
81
82
83
84
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】